Dose optimization of single-agent inotuzumab ozogamicin in adults with relapsed/refractory acute lymphoblastic leukemia.

Saved in:
Bibliographic Details
Title: Dose optimization of single-agent inotuzumab ozogamicin in adults with relapsed/refractory acute lymphoblastic leukemia.
Authors: DeAngelo, Daniel J.1 (AUTHOR), Chen, Ying2 (AUTHOR), Cassaday, Ryan D.3 (AUTHOR), Hibma, Jennifer E.2 (AUTHOR), Yang, Derek Z.2 (AUTHOR), Garrett, May2 (AUTHOR), Zhang, Fan2 (AUTHOR), Dimitrov, Svetoslav H.2 (AUTHOR), Vandendries, Erik R.2 (AUTHOR), Kantarjian, Hagop M.4 (AUTHOR) hkantarjian@mdanderson.org
Source: Leukemia & Lymphoma. Aug2026, p1-11. 11p. 3 Illustrations.
Database: Academic Search Ultimate
Description
ISSN:10428194
DOI:10.1080/10428194.2026.2714343